DIA webinar with SureClinical Explains New Electronic Trial Master File (eTMF) Data Standards
Rancho Cordova, California (PRWEB) October 08, 2014 -- DIA and SureClinical will co-host the complimentary webinar "How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality" on October 28 from 11 a.m. to 12:15 p.m. EDT.
In addition to DIA and SureClinical, speakers from the National Cancer Institute (NCI), ACT Oncology and CareLex will discuss the importance of data standards in clinical trials, and how the new OASIS eTMF Standard is being applied in clinical trials.
"This webinar will bring together industry experts to discuss data standards, and how the new OASIS eTMF Standard can be used to improve clinical trial operational efficiencies, collaboration and data sharing between sponsors, clinical research organizations, investigators and clinical trial stakeholders," said Zachariah Schmidt, President and CEO, SureClinical.
An overview of the draft OASIS eTMF Standard will be presented, including details on how organizations can benefit by using the eTMF controlled vocabulary terms hosted by the National Cancer Institute (NCI). Attendees will learn how the OASIS eTMF Standard and NCI’s term database will help their organization improve data consistency and data portability between organizations involved in clinical trials. ACT Oncology will share their criteria for selecting an eTMF solution and the business benefits of data standards.
Register today for the webinar to learn from these experts:
-Margaret W. Haber, RN, Program Manager, National Cancer Institute Enterprise Vocabulary Services
-Rob Ott, MBA, Executive Director, ACT Oncology
-Jennifer Alpert Palchak, CEO, CareLex; Co-Chair OASIS eTMF Standard Technical Committee
-Zack Schmidt, CEO, Co-Chair OASIS eTMF Standard Technical Committee
-Lou Chappuie, COO, SureClinical; Member, OASIS eTMF Standard Technical Committee
To register for the Webinar visit: DIA eTMF Webinar
About SureClinical
Based in Northern California, SureClinical provides cloud-based health science applications that automate business processes and eliminate paper. SureClinical’s Certified Cloud includes integrated document completion, Esigning and archiving for networks of health science organizations that wish to share documents in an automated, regulated cloud environment. SureClinical’s applications run on Android®, Apple® iPad, Apple® IOS, and other popular smartphone platforms, as well as on all major web browsers. For more information, visit http://www.SureClinical.com/etmf-events/
ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA's network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA, and regional offices covering North and South America (Horsham, Pa., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing).
###
Zack Schmidt, SureClinical Inc, 916-265-2000, [email protected]
Share this article